McKesson Corporation $MCK Shares Acquired by Groupama Asset Managment

Groupama Asset Managment grew its holdings in McKesson Corporation (NYSE:MCK) by 28.9% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 3,596 shares of the company’s stock after buying an additional 807 shares during the period. Groupama Asset Managment’s holdings in McKesson were worth $2,778,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. GGM Financials LLC acquired a new position in McKesson in the third quarter valued at about $25,000. State of Wyoming purchased a new position in McKesson during the second quarter worth about $29,000. Hopwood Financial Services Inc. acquired a new stake in shares of McKesson during the third quarter valued at about $31,000. Vermillion & White Wealth Management Group LLC acquired a new stake in shares of McKesson during the third quarter valued at about $33,000. Finally, Abound Wealth Management raised its stake in shares of McKesson by 104.3% in the 3rd quarter. Abound Wealth Management now owns 47 shares of the company’s stock valued at $37,000 after acquiring an additional 24 shares during the period. 85.07% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on MCK shares. Weiss Ratings cut shares of McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Thursday, February 5th. Zacks Research lowered McKesson from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 25th. Morgan Stanley restated an “overweight” rating and set a $966.00 price target on shares of McKesson in a research note on Thursday, January 29th. Raymond James Financial set a $970.00 price target on McKesson in a research report on Thursday, March 5th. Finally, Mizuho lifted their price objective on McKesson from $880.00 to $885.00 and gave the company a “neutral” rating in a research note on Thursday, February 5th. Thirteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $960.93.

Insiders Place Their Bets

In other news, EVP Thomas L. Rodgers sold 276 shares of the business’s stock in a transaction dated Monday, January 5th. The stock was sold at an average price of $816.18, for a total transaction of $225,265.68. Following the completion of the transaction, the executive vice president directly owned 2,268 shares of the company’s stock, valued at approximately $1,851,096.24. The trade was a 10.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Leann B. Smith sold 190 shares of the company’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total transaction of $179,550.00. Following the sale, the executive vice president owned 2,989 shares in the company, valued at $2,824,605. The trade was a 5.98% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 3,868 shares of company stock worth $3,743,820. Corporate insiders own 0.08% of the company’s stock.

McKesson Stock Performance

NYSE MCK opened at $898.82 on Friday. The firm has a market cap of $110.10 billion, a price-to-earnings ratio of 25.85, a PEG ratio of 1.48 and a beta of 0.38. The firm has a 50 day simple moving average of $902.24 and a 200-day simple moving average of $831.10. McKesson Corporation has a one year low of $637.00 and a one year high of $999.00.

McKesson (NYSE:MCK) last announced its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, topping the consensus estimate of $9.19 by $0.15. The firm had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The firm’s revenue for the quarter was up 11.4% on a year-over-year basis. During the same period in the prior year, the firm earned $8.03 EPS. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Equities analysts predict that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be paid a $0.82 dividend. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. The ex-dividend date is Monday, March 2nd. McKesson’s dividend payout ratio (DPR) is presently 9.43%.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.